김홍기 교수
Hong-Gee Kim
서울대학교 치의학과 · 컴퓨터과학
연구실 소개
김홍기 교수의 연구실은 인공지능 기반의 다중 -오믹스 데이터 통합 분석을 핵심으로 하여 폐암, 간암, 알츠하이머병 등 주요 질환의 조기 진단 및 병태생물학적 기반 규명을 목표로 합니다. 특히 그래프 신경망, 딥러닝 기반의 단백질-화합물 상호작용 예측, 그리고 대규모 유전자 데이터를 활용한 질병의 세포 기원 분석 등 정밀의료와 신약 개발에 기여할 수 있는 기초-임상 연계 연구를 진행하고 있습니다. 또한, 임상 적용에 적합한 저비용·고정확도의 머신러닝 모델 개발을 통해 의료 현장의 접근성 향상에도 기여하고 있습니다.
연구 현황
연구 성과 추이
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
주요 논문
15Early diagnosis of lung cancer to increase the survival rate, which is currently at a low range of mid-30%, remains a critical need. Despite this, multi-omics data have rarely been applied to non-small-cell lung cancer (NSCLC) diagnosis. We developed a multi-omics data-affinitive artificial intelligence algorithm based on the graph convolutional network that integrates mRNA expression, DNA methylation, and DNA sequencing data. This NSCLC prediction model achieved a 93.7% macro F1-score, indicati
Primary liver tissue cancer types are renowned to display a consistent increase in global disease burden and mortality, thus needing more effective diagnostics and treatments. Yet, integrative research efforts to identify cell-of-origin for these cancers by utilizing human specimen data were poorly established. To this end, we analyzed previously published whole-genome sequencing data for 384 tumor and progenitor tissues along with 423 publicly available normal tissue epigenomic features and sin
Analysis of compound-protein interactions (CPIs) has become a crucial prerequisite for drug discovery and drug repositioning. In vitro experiments are commonly used in identifying CPIs, but it is not feasible to discover the molecular and proteomic space only through experimental approaches. Machine learning's advances in predicting CPIs have made significant contributions to drug discovery. Deep neural networks (DNNs), which have recently been applied to predict CPIs, performed better than othe
<b>Background:</b> Cerebral amyloid beta (Aβ) is a hallmark of Alzheimer's disease (AD). Aβ can be detected <i>in vivo</i> with amyloid imaging or cerebrospinal fluid assessments. However, these technologies can be both expensive and invasive, and their accessibility is limited in many clinical settings. Hence the current study aims to identify multivariate cost-efficient markers for Aβ positivity among non-demented individuals using machine learning (ML) approaches. <b>Methods:</b> The relation
BACKGROUND: Metabolic pathway prediction is one possible approach to address the problem in system biology of reconstructing an organism's metabolic network from its genome sequence. Recently there have been developments in machine learning-based pathway prediction methods that conclude that machine learning-based approaches are similar in performance to the most used method, PathoLogic which is a rule-based method. One issue is that previous studies evaluated PathoLogic without taxonomic prunin
BACKGROUND AND OBJECTIVE: Large language models (LLMs) hold transformative potential for clinical decision-making in the rapidly advancing field of AI in medicine. This study evaluates how Chain-of-Thought (CoT) prompting techniques affect medical reasoning performance with consideration for clinical applicability. METHODS: Five LLMs (GPT-4o-mini, GPT-3.5-turbo, o1-mini, Gemini-1.5-Flash, Gemini-1.0-pro) were assessed via API access using CoT prompting methods exhibiting distinct cognitive chara
대표 연구 분야
김홍기 교수의 연구를 Nubint에서 더 깊이 살펴보세요
이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.